Autoantibodies against platelet-derived growth factor receptor alpha in patients with systemic lupus erythematosus
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-10-01
著者
-
Kurasawa Kazuhiro
Pulmonary Medicine And Clinical Immunology Dokkyo University School Of Medicine
-
Maezawa Reika
Pulmonary Medicine And Clinical Immunology Dokkyo University School Of Medicine
-
Kumano Kotaro
Pulmonary Medicine And Clinical Immunology Dokkyo University School Of Medicine
-
Owada Takayoshi
Clinical Immunology School Of Medicine Dokkyo Medical University
-
Fukuda Takeshi
Pulmonary Medicine And Clinical Immunology Dokkyo University School Of Medicine
-
KURASAWA Kazuhiro
Clinical Immunology, School of Medicine, Dokkyo Medical University
-
ARAI Satoko
Clinical Immunology, School of Medicine, Dokkyo Medical University
-
MAEZAWA Reika
Clinical Immunology, School of Medicine, Dokkyo Medical University
-
KUMANO Kotaro
Clinical Immunology, School of Medicine, Dokkyo Medical University
-
FUKUDA Takeshi
Clinical Immunology, School of Medicine, Dokkyo Medical University
-
Arai Satoko
Pulmonary Medicine And Clinical Immunology Dokkyo University School Of Medicine
-
Fukuda Takeshi
Clinical Immunology Dokkyo Medical University School Of Medicine
-
Maezawa Reika
Clinical Immunology Dokkyo Medical University School Of Medicine
-
Kurasawa Kazuhiro
Clinical Immunology Dokkyo Medical University School Of Medicine
-
Arai Satoko
Clinical Immunology Dokkyo Medical University School Of Medicine
関連論文
- Rituximab was effective on refractory thrombotic thrombocytopenic purpura but induced a flare of hemophagocytic syndrome in a patient with systemic lupus erythematosus
- Autoantibodies against platelet-derived growth factor receptor alpha in patients with systemic lupus erythematosus
- Reactivation of cytomegalovirus predicts poor prognosis in patients on intensive immunosuppressive treatment for collagen-vascular diseases
- Systemic sclerosis complicated by arrhythmogenic right ventricular dysplasia that was misinterpreted as pulmonary arterial hypertension
- Positivity for anti-RNP antibody is a risk factor for adverse effects caused by trimethoprim-sulfamethoxazole, a prophylactic agent for P. jiroveci pneumonia, in patients with connective tissue diseases